BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25796442)

  • 21. Involvement of the PLCε/PKCα pathway in human BIU-87 bladder cancer cell proliferation.
    Ling Y; Chunli L; Xiaohou W; Qiaoling Z
    Cell Biol Int; 2011 Oct; 35(10):1031-6. PubMed ID: 21121899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation.
    Yu Y; Zhang Y; Guan W; Huang T; Kang J; Sheng X; Qi J
    Mol Cancer Res; 2014 Jun; 12(6):830-42. PubMed ID: 24574517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH
    Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.
    Stoyanova T; Riedinger M; Lin S; Faltermeier CM; Smith BA; Zhang KX; Going CC; Goldstein AS; Lee JK; Drake JM; Rice MA; Hsu EC; Nowroozizadeh B; Castor B; Orellana SY; Blum SM; Cheng D; Pienta KJ; Reiter RE; Pitteri SJ; Huang J; Witte ON
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6457-E6466. PubMed ID: 27694579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin mitigates PLCε gene expression and modulates the Notch1/Hes and androgen receptor signaling pathways in castration-resistant prostate cancer xenograft models.
    Li Q; Xu K; Tian J; Lu Z; Pu J
    Oncol Lett; 2021 Oct; 22(4):715. PubMed ID: 34429755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
    Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
    Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer.
    Audet-Walsh É; Vernier M; Yee T; Laflamme C; Li S; Chen Y; Giguère V
    Mol Cancer Res; 2018 Sep; 16(9):1396-1405. PubMed ID: 29784665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
    Mashima T; Okabe S; Seimiya H
    Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S
    Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
    Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prostate cancer-up-regulated Myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor.
    Jiao L; Li Y; Shen D; Xu C; Wang L; Huang G; Chen L; Yang Y; Yang C; Yu Y; Sun Y
    Med Oncol; 2013; 30(2):570. PubMed ID: 23609189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
    Bennett NC; Hooper JD; Johnson DW; Gobe GC
    Prostate; 2014 May; 74(5):478-87. PubMed ID: 24375805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Wnt signaling inhibits the pro-apoptotic role of Notch in gastric cancer cells.
    Li H; Mo J; Jia G; Liu C; Luan Z; Guan Y
    Mol Med Rep; 2013 Jun; 7(6):1751-6. PubMed ID: 23563575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
    Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G
    Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
    Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
    Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
    Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
    J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
    Zayzafoon M; Abdulkadir SA; McDonald JM
    J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells.
    Soylu H; Kırca M; Avcı S; Ozpolat B; Ustunel I
    Exp Mol Pathol; 2021 Apr; 119():104607. PubMed ID: 33482170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.